Cantor Fitzgerald Maintains Overweight Rating for AVITA Medical with $21 Price Target
Dec 24, 2024
Avita Stock Market Invest
AVITA Medical Reduces FY23 Revenue Projections Among Notable Stock Movements
Nov 22, 2023